Opdualag

Indicated For

advanced melanoma

About This Medication

# Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) Patient Guide: How to Get Opdualag (nivolumab and relatlimab-rmbw) at Low or No Cost Opdualag (nivolumab and relatlimab-rmbw) is a prescription immunotherapy combination used to treat certain types of advanced melanoma in adults. This guide explains how the **Bristol Myers Squibb Patient Assistance Foundation (BMSPAF)** can help eligible patients get **Opdualag** for free if you face financial hardship, lack insurance coverage, or struggle with high out-of-pocket costs. ## About Opdualag **Opdualag** is an intravenous (IV) infusion medication approved by the FDA for unresectable or metastatic melanoma. It combines two checkpoint inhibitors—**nivolumab** (blocks PD-1) and **relatlimab-rmbw** (blocks LAG-3)—to help your immune system fight cancer cells more effectively. Administered every 4 weeks in a healthcare setting, it targets adults whose melanoma cannot be removed by surgery or has spread. Common side effects include fatigue, rash, muscle pain, itching, diarrhea, nausea, and more serious immune-related issues like thyroid problems or organ inflammation. Always discuss risks and benefits with your doctor. BMSPAF provides **Opdualag** at no cost to qualifying patients, removing financial barriers to this critical treatment.[1][3][5] ## Who Qualifies for BMSPAF? BMSPAF is designed for U.S. residents (including Puerto Rico) aged 18+ facing financial challenges. Key eligibility factors include: - **Financial need**: Household income below BMSPAF limits (exact thresholds not publicly specified; evaluated case-by-case with proof of income).[3][5] - **Insurance status**: Uninsured, underinsured (e.g., high copays), Medicare Part D patients who spent ≥3% of yearly household income on out-of-pocket prescription costs, Medicaid, or no prescription coverage.[1][3] - **Residency**: Must live in the U.S. or Puerto Rico. - **Prescription**: Valid prescription for Opdualag from a U.S. licensed provider. - **Other**: No minimum age beyond 18; not for those with active commercial insurance covering the drug fully. Medicare patients qualify if meeting the 3% spend threshold; reapply annually in January.[5] Applications are free and reviewed individually.[4] ## Income Eligibility Breakdown BMSPAF does not publish fixed Federal Poverty Level (FPL) percentages or household-specific thresholds online. Eligibility hinges on demonstrating financial hardship via income proof, household size, and expenses. Income must be below program limits, with special consideration for Medicare out-of-pocket costs.[3] Here's a general overview based on program guidelines (consult BMSPAF for your situation): | Household Size | Estimated Income Limit | Notes | |---------------|-----------------------|-------| | 1 (Individual) | Below program threshold (case-by-case) | Proof of income required; Medicare ≥3% OOP spend qualifies.[3] | | 2 (Couple) | Below program threshold | Include all household income sources.[1] | | 3 | Below program threshold | Larger families may have adjusted limits. | | 4+ | Below program threshold | Provide full household details. | **Tip**: Gather recent tax returns, pay stubs, or benefit statements. No strict FPL % listed, but low-income/uninsured prioritized.[1][2] ## Insurance Requirements BMSPAF targets those without adequate coverage: - **Uninsured**: No prescription insurance (private, public, VA, etc.).[3] - **Underinsured**: Medicare Part D with ≥3% household income spent on OOP costs; high copays unaffordable.[3][5] - **Medicaid/State programs**: Eligible if no/low coverage for Opdualag.[3] - **Exclusions**: Active private insurance fully covering the drug; must exhaust other options first. List all insurances on the form (Medicare A/B/D, Medicaid, etc.). Provider confirms no coverage or unaffordable costs.[3][4] ## Step-by-Step Application Process BMSPAF offers multiple application methods. Start by calling **(800) 721-5072** or visiting bmspaf.org.[6] 1. **Confirm eligibility**: Discuss with your doctor; ensure valid Opdualag prescription. 2. **Download form**: Get from bmspaf.org, doctor's office, or RxHope.[1][2][4] 3. **Gather documents**: - **Proof of income** (tax return, W-2, pay stubs, SSI/SSDI letters). - **Proof of insurance status** (insurance cards, denial letters, OOP receipts for Medicare). - **Prescription** (do not attach to form; provider handles).[4] 4. **Complete patient section**: Personal info, household size/income, insurance, medications, signature.[2][3] 5. **Doctor completes**: Provider sections (diagnosis, prescription, coverage confirmation), signs.[2] 6. **Submit**: - **Mail/Fax**: Per form instructions.[2][4] - **Phone assistance**: Call (800) 721-5072 for help.[6] - Online options may vary; check site.[1] 7. **Track status**: Call for updates; decisions in weeks.[1] **Pro tip**: Review for accuracy—errors delay processing.[1][4] ## Timeline and Delivery - **Processing**: Varies; expect decision in a few weeks. Check status via phone.[1][4] - **Approval duration**: Up to 1 year (90-day supplies); Medicare reapply Jan.[5] - **Delivery**: Free medication shipped to **physician's office** or **patient's home** in 90-day increments.[4][5] - **Refills**: Reauthorization required; reapply before supply ends.[5] ## Alternatives if Denied - **Appeal**: Contact BMSPAF (800-721-5072) with updated docs.[1] - **BMS Access Support**: Insurance navigation, copay help (bmsaccesssupport.com).[7][8] - **Other PAPs**: PAN Foundation, HealthWell (check eligibility for oncology). - **Patient Access Network**: Grants for copays. - **State programs**: Medicaid extra help. - **Manufacturer copay cards**: If commercially insured (not for gov't insurance).[7] - **No biosimilars** for Opdualag currently.[ ] Discuss with your oncology social worker. ## Disclaimer This guide is for informational purposes based on publicly available BMSPAF details as of 2026. Program rules change; eligibility not guaranteed. Contact BMSPAF directly at (800) 721-5072 or bmspaf.org for latest info. Consult your healthcare provider before starting/stopping Opdualag. Not medical/financial advice.

Program information last verified: March 25, 2026